The label criteria, what our physicians review, why BMI isn’t perfect for muscular men, and who shouldn’t take it.
Find Your Body ProtocolFDA-approved Tirzepatide for weight management is labelled for adults with a BMI of 30 or more, or 27 or more with a weight-related condition such as high blood pressure, high cholesterol or sleep apnea. With MANE & STEEL, a licensed physician reviews your BMI, waist, health history, medications and goals, and compounded Tirzepatide is prescribed only when the physician decides it’s appropriate for you. People with a personal or family history of medullary thyroid cancer or MEN 2 shouldn’t take it.
The approved weight-management product (Zepbound) is labelled for adults with:
It’s meant to be used alongside a reduced-calorie diet and more physical activity.
After checkout you complete a short medical intake. A licensed U.S. physician reviews your height, weight and BMI, your waist, your health history and family history, every medication and supplement you take, any recent labs, and your goals. They decide whether compounded Tirzepatide is appropriate for you and, if so, your starting dose. Every prescription is written for you as an individual.
Prescription required. Not approved? You get a full refund.
BMI only uses height and weight, so it can overstate body fat in muscular men. That’s why physicians also look at waist size, health markers and history rather than BMI alone. It works both ways, though: a high BMI from muscle isn’t a reason to prescribe. The physician is looking for excess fat that’s affecting your health.
Your physician also screens for a history of pancreatitis, gallbladder disease, kidney problems, severe stomach or bowel problems, diabetic eye disease, and medications such as insulin or a sulfonylurea that raise the risk of low blood sugar.
Not yet. We can’t currently ship compounded Tirzepatide to Arkansas, Indiana or South Carolina. You must be 18 or older and live in a state we serve.
Prescription required. A licensed physician decides whether compounded Tirzepatide is appropriate for you, and your dose.
Boxed warning: risk of thyroid C-cell tumors. In animal studies, Tirzepatide caused thyroid C-cell tumors. It is unknown whether it causes these tumors, including medullary thyroid carcinoma (MTC), in people. Do not use Tirzepatide if you or a family member have ever had MTC, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Possible serious side effects include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or a sulfonylurea), kidney problems from dehydration and serious allergic reactions.
The most common side effects are nausea, diarrhea, vomiting, constipation, stomach pain, indigestion and decreased appetite.
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality. Compounded Tirzepatide is prepared by Strive Pharmacy, a state-licensed 503A compounding pharmacy. Not available in Arkansas, Indiana or South Carolina.
Two minutes of questions, then a short medical intake. A licensed physician decides whether compounded Tirzepatide is appropriate for you, and your dose. Not approved? Full refund.